Rhabdomyolysis Caused by Gefitinib Overdose |
| |
| Authors: | Shohei Obayashi Katsuyoshi Tomomatsu Mika Urata Jun Tanaka Kyoko Niimi Naoki Hayama Tsuyoshi Oguma Koichiro Asano Yoko Ito |
| |
| Affiliation: | 1.Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan |
| |
| Abstract: | ![]()
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are common therapeutic agents for EGFR mutation-positive advanced non-small-cell lung cancer. There has been no report of rhabdomyolysis caused by an overdose of EGFR-TKIs. We herein review the existing literature on the subject and report a rare case of rhabdomyolysis due to an overdose of gefitinib, an EGFR-TKI. |
| |
| Keywords: | EGFR-TKI rhabdomyolysis overdose |
|
